【藥品庫存】 藥品安全警訊：本品部份批號因不純物檢測結果偏離預期，於 2024/3/21 來文公告回收。【院內目前使用的非回收批號】。 更新日期：2024/3/21。

For management of Seasonal allergic rhinitis.

Fexofenadine is a second-generation, long lasting H1-receptor antagonist (antihistamine) which has a selective and peripheral H1-antagonist action.

Onset of action: 60 minutes; Duration: antihistaminic effect: ≧12 hours; plasma protein binding: 60-70%; Elimination Half- life: 14.4 hours( prolonged in renal impairment ); Excretion: feces (~80%) and urine (~11%) as unchanged form. Not effectively removed by hemodialysis.

Hypersensitivity to fexofenadine or any component of the formulation

C

Excretion in breast milk unknown/use caution (AAP rates “compatible”)

dizziness, headache, drowsiness, fatigue, vomiting (children 6 months to 5 years: 4% to 12%)

Adults and children(>12 years) with normal function: 60 mg orally twice daily or 180 mg once daily with water.
Children 2-11 years: 30 mg twice daily.
Do not take concurrently or closely in time with aluminum and magnesium containing antacids

Dose adjustments according to ClCr (ml/min), Adults and children (>12 years): 41-80 ml/min, 60 mg QD; <40 ml/min, 30 mg QD.